Objective To develop predictive models for early triage of burn patients based on hyper-susceptibility to 35 repeated infections.
0.794-0.933]; AUROC Genomic /AUROC Clinical P = 0.044). Combined model has an increased
INTRODUCTION 62
Although several studies have found association between specific risk factors or clinical characteristics 63 with mortality after trauma, [1] [2] [3] [4] studies attempting to apply those clinical characteristics or genomic 64 biomarkers to appreciate susceptibility to infection and build predictive models are currently lacking. and hyper-susceptible patients, Benjamini-Hochberg multiple-comparison adjustments were applied to 158 control for false discovery rate.
159
Development of the clinical predictive models. We implemented stepwise logistic regression 160 with an entry level of 0.3 and a stay level of 0.25 to identify significant predictor variables among clinical 161 covariates relevant to the outcome variable of MIE: TBSA, age, BMI, and the presence of inhalation 162 injury. We determined predictive power by calculating area under receiver operating characteristic curve 163 (AUROC), reported with 95% confidence intervals (CIs).
164
Development of the genomic predictive models. We used the LASSO regularized regression 165 method 38 implemented in the glmnet package 39 in R software to identify probe sets that collectively 166 predicted the likelihood of MIE. We used 10-fold cross-validation (CV) to select the optimal value of 167 LASSO penalty weighting, λ. The value of λ that gave the minimum average binomial deviance plus 1 168 standard error on the test set, λ 1se , was used to select probe sets ( Figure 3A) . λ 1se is a stronger penalty 169 parameter to guard against over-fitting than λ min , which minimizes the average binomial deviance of CV 170 ( Figure 3B ). This 10-fold CV process was repeated 100 times to generate 100 λ 1se values. The median λ 1se , 171 0.0940, yielded selection of a 14-probe-set biomarker panel ( Figure 3C ; Table 2 ). Logistic regression was 172 performed to model the MIE outcome with the log 2 expression values of the 14 probe sets as explanatory 173 variables. Furthermore, we conducted multivariate logistic regression with the clinical covariates TBSA, 174 age, and inhalation injury together with the 14 probe sets for the outcome variable of MIE. Leave-one-out 175 cross-validation was used to assess the degree of over-fitting and model performance.
177

Functional Analysis
Functional and pathway analyses were conducted using Ingenuity IPA (Ingenuity® Systems, R (version 2.15.*); EMA package for R (version 1.3.2); pROC package for R (version 1.5.4); limma 183 package for R (version 3.14.4); glmnet package for R (version 1.9-3); arrayQualityMetrics package for R 184 (version 3.14 (Table 1 ). Relative to the control 198 group, hyper-susceptible patients were slightly older (mean, 38.2, SD 16.4 vs 37.0, SD 14.6), had higher 199 TBSA (46%, IQR 35-71 vs 32%, IQR 23-41, P < 0.0001), had more inhalation injuries (41/66 [62.1%] 200 vs 8/47 [17.0%], P < 0.0001) and were more severely ill (according to their APACHE II score 24, IQR 201 18-29 vs 13, IQR 9-20, P < 0.0001). They also had longer hospital stays (median, 60, 202 IQR 15-30, P < 0.0001), more days on mechanical ventilation (median, 28, IQR13-40 vs 2, IQR 0-5, P < 203 0.0001), and had a higher mortality (18/66 [27.3%] vs 3/47 [6.4%], P = 0.0029) ( Table 1 ). The median 204 post-injury interval for the second episode in the case group was 15 days (IQR, 10-20; range, 3-43), a time window that provides opportunity for prophylactic intervention. 
234
Ten-fold CV using LASSO regularized regression 38 of the 1142 probe sets that presented a minimum of 235 1.5-fold change between the two patient groups yielded a minimal set of 14 predictors (probe sets) that 236 together optimized the fit of the model ( Figure 4A and 4B). Of these 14 probe sets-which mapped to 12 237 genes-4 were upregulated and 10 were down-regulated (Table 2, all P < 0.01; see Figure 4C for heat 238 map and clustering of patients and biomarkers; see Figure 2 for expression profiles of each probe set).
239
The biological processes associated with each probe set are presented in Table 3 together with the 240 coefficients of the biomarker panel logistic regression model (model intercept = 0.7449; SDC Table 6 ).
241
The AUROC, CV AUROC, sensitivity, and specificity values for the resulting genomic signature model 242 are 0.946 (95% CI, 0.906-0.986), 0.872 (95% CI, 0.804 -0.940), 0.924 (95% CI, 0.825-0.972), and 0.830 243 (95% CI, 0.687-0.919), respectively ( Figure 3 ), confirming the model to be highly sensitive and specific.
244
The positive and negative predictive values of the model were 0.884 (95% CI, 0.779-0.945) and 0.886 245 (95% CI, 0.746-0.957), respectively. We compared each patient's probability of developing MIE 246 estimated from our clinical or genomic biomarker logistic regression models with each of the observed 247 outcomes, using cut-off points of 30% to 70% as being uncertain. We found that the clinical model 248 correctly predicted outcomes of 73 (65%) patients with certainty. Comparatively, the genomic biomarker Table 3 ).
275
The top 30 affected pathways were mainly involved in immune cell signaling and cytokine signaling 276 ( Figure 5 ). Canonical pathway analysis using IPA software ( Figure 5 ) largely agrees with KEGG pathway enrichment analysis using DAVID (SDC Table 5 ), providing additional confidence. Overall, many of the 278 predicted functional changes ( Table 2) 
291
We found strong evidence that T-cells were also differentially regulated in case patients. Several Tables 2, 3, and 4) . Notably, 42 probe sets (39 genes) have functional annotation 303 associated with chromatin remodeling and histone modifications (SDC Table 4 ). Two genes from the 304 biomarker panel involved in epigenetic modulation were found to be down-regulated in the case group 305 with MIE: WHSC1L1, which encodes a histone lysine methyltransferase; and SMARCA4, which encodes 306 an ATP-dependent helicase related to the SWI/SNF chromatin remodeling factor. A multitude of 307 differentially expressed genes encoding histone post-translational modifiers as well as key components of 308 the nucleosome remodeling complex mediating ATP-dependent nucleosome sliding, including 309 SMARCC1, SMARCA4, CHD2 and CHD9, were down-regulated (SDC Table 4 ). Other notable histone 310 methyltransferases/demethylases differentially expressed include KDM4, KDM5C, KDM6, PRDM5, 311 SETD2, SETDB2, and SUZ12. Genes coding for histone deacetylases/acetyltransferases and associated 312 factors including HDAC9, KAT6A and EP400 were down-regulated and histone acetylation recognizing 313 bromodomain containing protein, BRD2, was upregulated in the case group. Furthermore, critical non-314 histone heterochromatin proteins HP1-α and -γ were down-regulated, as well as core histone cluster.
315
Taken together, our data may suggest a global loss of heterochromatin and genome instability, as well as 316 probable gene-specific transcriptional deregulation in hyper-susceptible patients compared to controls.
318
DISCUSSION
319
The work presented reports novel predictive models for hyper-susceptibility to infection among 320 traumatically injured patients, using genomic biomarkers and/or clinical characteristics that have not been 321 used to build statistical prognostic models for the purpose of predicting infection outcomes. We provide 322 evidence that our models can identify burn patients at high risk of developing repeated infections 323 indicative of their hyper-susceptible state. To our knowledge, this work is the first to describe such 324 models in trauma patients, and the first to describe functional transcriptome data of burn patients in relation to infections. The prediction accuracy of hyper-susceptibility to MIE is significantly increased 326 over clinical markers when the genomic signature is used, providing strong evidence of the promising role 327 of genomic biomarkers in prognosis even when used alone. By combining the biomarker panel with 328 clinical characteristics, we demonstrated even better prediction accuracy, supporting the tremendous 329 potential of using genomic signature to increase confidence in data used for treatment decision-making.
331
Clinical Implications.
332
We identified two distinct patient groups with different genomic signatures and clinical characteristics, 333 essentially allowing the rapid identification of patients with a high risk of developing MIE following burn 334 trauma. Although burn patients generally suffer from immunosuppression, clinical experience and our 335 data suggest that the severity of immunosuppression and infection outcome vary. These data suggest that 336 patients could potentially receive personalized therapy depending on their susceptibility to infection, 337 triaged by physical exam and a blood test on admission. This information could facilitate the 338 determination of appropriate treatment courses, particularly in regards to antibiotic use, allowing for 339 selective use of prophylactic antibiotics and more objective justification of length of treatment courses.
340
For the patient, this could limit complications related to unneeded antibiotics, reduce the burden of lines 341 needed to deliver the antibiotics, and streamline hospital care. For the population, this could promote 342 antibiotic stewardship, help stem the emergence of resistant organisms, and reduce the cost of care. 
361
Thus, building on convergent findings in humans and mice, our data confirm that processes related to 362 coagulation play important roles in sepsis, and suggest that THBS1 could be a novel target for sepsis 363 prevention and treatment.
364
We showed evidence for increased chemotaxis, cell adhesion, and migration of immune cells, and 365 simultaneously, decreased expansion of immune cells and development of lymphatic system components.
366
This seeming contradiction may well be the consequences of dysfunctional immune system and cytokine 367 signaling, especially in T-cells.
368
Our data suggest that epigenetic changes occur early on, rather than mainly as a consequence of 369 septic shock. Epigenetic regulation of immune system is a common mechanism for gene expression 370 regulation and it plays a role in long-term immunosuppression after sepsis. 46 Tightly regulated chromatin 371 remodeling is required for transcriptional regulation, which is vital for proper host immune and 372 inflammatory responses. 47 Among the genes associated with epigenetic regulations, several have confirmed roles in immune responses, such as KAT6A and KDM6B (SDC Table 4 ). 46, [48] [49] [50] 
390
We envision that the development of a comprehensive diagnostic tool set will depend on the 391 integration of genomic signatures of both host and pathogen. The blood biomarkers reported could be 392 further developed and integrated with other diagnostic tools, such as genomic single nucleotide 393 polymorphisms (SNPs) that predispose certain patients to infection, 51,52 and produce a more 394 comprehensive prognosis of patient susceptibility. Physician decisions rely heavily on blood tests over the 395 course of recovery, and a positive culture is still the most accepted and reliable method for diagnosing 396 infection. Using biomarkers, these blood samples could also allow us to monitor the changes in susceptibility status and adjust treatments accordingly. Modern molecular based microbiological tests, 53 398 such as detection of P. aeruginosa in wound biopsy using RT-PCR based assays, 54 have been developed 399 but not yet widely utilized. Several molecular early detection kits have become commercially available 400 for diagnosing common bloodstream infections, and have been found to show some promise despite of 401 much room left for improvement. 55, 56 Our biomarkers on the host response may work synergistically with 402 these tests to support physician decisions.
403
The discovery of these biomarkers and the validation of the methods pave the way for identifying 
408
This study is limited by the unavailability of pathogen genotyping information below species 409 level. We could not distinguish whether a reoccurring infection was caused by persistent or MDR 410 pathogen, and could not identify biomarkers that can potentially differentiate susceptibility to different 411 pathogens, such as Gram positive/negative bacteria, and even to species level. Nonetheless, our 6-day 412 window (SDC Figure 1B) was designed to minimize infection episodes caused by the same strain(s). Our 413 definition of hyper-susceptibility is based on natural definition of having repeated infections. Changing 414 this definition, for example, to having at least three infection episodes, did not significantly change the 415 biomarkers identified (data not shown). However, the P values for differential gene expression and 416 clinical characteristics became less significant, suggesting either the criterion is not the best cut off point 417 to separate two different groups, or that the statistical power is reduced due to smaller number of patients 418 in the hyper-susceptible group.
419
Although this work and our model focused on thermally injured trauma patients, our approach is 420 potentially applicable to other types of trauma and surgical patients. In this study, to ensure portability of our models, we carried out rigorous internal CV to ensure robustness of our regression models. However, 422 due to the novelty of this clinical and transcriptome dataset, independent cohort data was unavailable for 423 CV. Although our dataset is the largest of its kind to date, the sample size is still too small to build a Table 2 for Affymetrix probe identification). The heat map color-coding is 584 based on probe-set-specific, re-normalized expression values, with red signifying upregulation, blue 
Mini-Abstract
Early genomic signature and clinical characteristics of 113 burn patients were used paradigmatically to build three novel predictive models of multiple, repeated infections in burn trauma, which could facilitate early triage of traumatically injured burn patients to prevent or treat sepsis. Genomic signature suggests new mechanistic aspects of hyper-susceptibility to infections.
ABSTRACT
Objective To develop predictive models for early triage of burn patients based on hypersusceptibility to repeated infections.
Background Infection remains a major cause of mortality and morbidity after severe trauma, demanding new strategies to combat infections. Models for infection prediction are lacking.
Methods Secondary analysis of 459 burn patients (≥16 years old) with ≥20% total body surface area burns recruited from six US burn centers. We compared blood transcriptomes with a 180-h cut-off on the injury-to-transcriptome interval of 47 patients (≤1 infection episode) to those of 66 hyper-susceptible patients (multiple [≥2] infection episodes [MIE] ). We used LASSO regression to select biomarkers and multivariate logistic regression to built models, accuracy of which were assessed by area under receiver operating characteristic curve (AUROC) and cross-validation.
Results Three predictive models were developed covariates of: (1) clinical characteristics; (2) expression profiles of 14 genomic probes; (3) combining (1) Label:  Tables 1 -3  Filename: Tables.docx  Table 1 . Demographics and clinical characteristics of participants.
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All ( 196 An absolute z-score of ≥2 was designated as significant by the IPA software. The numbers of genes used to predict functional changes are indicated in the column with the heading "# of genes".
